Paul S. Freemont
- Molecular Biology top 0.2%
- RNA and protein synthesis mechanisms 34
- CRISPR and Genetic Engineering 27
- Retinoids in leukemia and cellular processes 22
- Ubiquitin and proteasome pathways 20
- Gene Regulatory Network Analysis 19
- Cell Biology top 0.2%
- Endoplasmic Reticulum Stress and Disease 26
- Endocrinology top 0.5%
- Hematology top 0.5%
- Immunology top 1%
-
- Bacterial Genetics and Biotechnology 26
-
- Enzyme Structure and Function 17
- Co-authors
- Xiaodong ZhangKatherine L. B. BordenMichael N. BoddyAndrew J. SaurinKirsten JensenHisao KondoRichard NewmanKaren M. Polizzi
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Paul S. Freemont
228 papers receiving 17.0k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Molecular Biology 13.7k
- Cell Biology 2.6k
- Endocrinology 532
- Hematology 1.1k
- Immunology 2.0k
Countries citing papers authored by Paul S. Freemont
This map shows the geographic impact of Paul S. Freemont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Freemont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Freemont more than expected).
Fields of papers citing papers by Paul S. Freemont
This network shows the impact of papers produced by Paul S. Freemont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Freemont. The network helps show where Paul S. Freemont may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul S. Freemont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 115 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 29 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 39 | |
| 13 | 2021 | 116 | |
| 14 | 2020 | 62 | |
| 15 | 2020 | 33 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 45 | |
| 18 | 2018 | 41 | |
| 19 | 2018 | 138 | |
| 20 | 2002 | 175 |
About Paul S. Freemont
Paul S. Freemont is a scholar working on Molecular Biology, Cell Biology and Endocrinology, having authored 232 papers that have together received 17.3k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (34 papers), CRISPR and Genetic Engineering (27 papers), Endoplasmic Reticulum Stress and Disease (26 papers), Bacterial Genetics and Biotechnology (26 papers), Retinoids in leukemia and cellular processes (22 papers), Ubiquitin and proteasome pathways (20 papers), Gene Regulatory Network Analysis (19 papers) and Enzyme Structure and Function (17 papers). The work is most often cited by research in Molecular Biology (13.7k citations), Cell Biology (2.6k citations) and Endocrinology (532 citations). Paul S. Freemont has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Xiaodong Zhang, Katherine L. B. Borden, Michael N. Boddy, Andrew J. Saurin, Kirsten Jensen, Hisao Kondo, Richard Newman, Karen M. Polizzi, Carol Shiels and Laurence D. Etkin. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.